Phosphodiesterase type 5 inhibitor (sildenafil) – impact in proliferative diabetic retinopathy?

Ani Korhonen; Erika Gucciardo; Kaisa Lehti; Sirpa Loukovaara

doi:10.1111/aos.15058

Phosphodiesterase type 5 inhibitor (sildenafil) – impact in proliferative diabetic retinopathy?

Ani Korhonen, Erika Gucciardo, Kaisa Lehti, Sirpa Loukovaara

Forskningsoutput: Tidskriftsbidrag › Brev › Vetenskaplig

Originalspråk	engelska
Tidskrift	Acta Ophthalmologica
Volym	100
Nummer	5
Sidor (från-till)	E1187-E1188
Antal sidor	2
ISSN	1755-375X
DOI	https://doi.org/10.1111/aos.15058
Status	Publicerad - aug. 2022
MoE-publikationstyp	B1 Artikel i en vetenskaplig tidskrift

Vetenskapsgrenar

3125 Öron-, näs- och halssjukdomar, ögonsjukdomar

Åtkomst av dokument

10.1111/aos.15058

Citera det här

@article{fadef354373c47e98d5829ad83f5e7f9,

title = "Phosphodiesterase type 5 inhibitor (sildenafil) – impact in proliferative diabetic retinopathy?",

keywords = "3125 Otorhinolaryngology, ophthalmology",

author = "Ani Korhonen and Erika Gucciardo and Kaisa Lehti and Sirpa Loukovaara",

note = "Funding Information: This study was supported by grants from the Sigrid Juselius Foundation (KL), Karolinska Institutet (KL), Finnish Eye Foundation (SL), Mary and Georg C. Ehrnrooth Foundation (SL), HUCH Clinical Research Grants (TYH2016230, TYH2019232, TYH2020225 and SL), Finnish Medical Foundation (SL) and Paulo Foundation (EG). ",

year = "2022",

month = aug,

doi = "10.1111/aos.15058",

language = "English",

volume = "100",

pages = "E1187--E1188",

journal = "Acta Ophthalmologica",

issn = "1755-375X",